DE60029252D1 - Anwendung von scopolaminsalzen - Google Patents

Anwendung von scopolaminsalzen

Info

Publication number
DE60029252D1
DE60029252D1 DE60029252T DE60029252T DE60029252D1 DE 60029252 D1 DE60029252 D1 DE 60029252D1 DE 60029252 T DE60029252 T DE 60029252T DE 60029252 T DE60029252 T DE 60029252T DE 60029252 D1 DE60029252 D1 DE 60029252D1
Authority
DE
Germany
Prior art keywords
application
scopolamine
salts
scopolamine salts
trauma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60029252T
Other languages
English (en)
Other versions
DE60029252T2 (de
Inventor
Moraes Mello Eugenio De
Massant Christina Goncalves
Benassi Simone Kastropil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUNDACAFO DE AMPARO A PESQUISA
Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP
Original Assignee
FUNDACAFO DE AMPARO A PESQUISA
Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUNDACAFO DE AMPARO A PESQUISA, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP filed Critical FUNDACAFO DE AMPARO A PESQUISA
Publication of DE60029252D1 publication Critical patent/DE60029252D1/de
Application granted granted Critical
Publication of DE60029252T2 publication Critical patent/DE60029252T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE60029252T 1999-12-17 2000-12-14 Anwendung von scopolaminsalzen Expired - Lifetime DE60029252T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BR9906220-8A BR9906220A (pt) 1999-12-17 1999-12-17 Uso de sais de escopolamina
BR9906220 1999-12-17
PCT/BR2000/000137 WO2001043745A1 (en) 1999-12-17 2000-12-14 The use of scopolamine salts

Publications (2)

Publication Number Publication Date
DE60029252D1 true DE60029252D1 (de) 2006-08-17
DE60029252T2 DE60029252T2 (de) 2007-07-05

Family

ID=36693764

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029252T Expired - Lifetime DE60029252T2 (de) 1999-12-17 2000-12-14 Anwendung von scopolaminsalzen

Country Status (12)

Country Link
US (1) US20030060481A1 (de)
EP (1) EP1259241B8 (de)
JP (1) JP2003530315A (de)
CN (1) CN1224389C (de)
AT (1) ATE332137T1 (de)
AU (1) AU1978201A (de)
BR (1) BR9906220A (de)
CA (1) CA2395037C (de)
DE (1) DE60029252T2 (de)
DK (1) DK1259241T3 (de)
MX (1) MXPA02005727A (de)
WO (1) WO2001043745A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532244A (en) * 1984-09-06 1985-07-30 Innes Margaret N Method of treating migraine headaches
US5011853A (en) * 1989-08-25 1991-04-30 Washington University Compounds for treatment of cholinergic neurotoxins
US5480651A (en) * 1992-03-16 1996-01-02 Regents Of The University Of California Composition and method for treating nicotine craving in smoking cessation
CN1089485A (zh) * 1993-01-03 1994-07-20 赵占民 复方天仙子通微灵片及其制备方法
CN1089473A (zh) * 1993-01-03 1994-07-20 赵占民 复方天仙子动静脉注射液及其制法
US5919802A (en) * 1997-12-05 1999-07-06 Princeton University Methods of preventing and/or treating temporal lobe epilepsy

Also Published As

Publication number Publication date
EP1259241B1 (de) 2006-07-05
EP1259241B8 (de) 2006-09-06
AU1978201A (en) 2001-06-25
EP1259241A1 (de) 2002-11-27
BR9906220A (pt) 2001-06-26
CN1224389C (zh) 2005-10-26
ATE332137T1 (de) 2006-07-15
DK1259241T3 (da) 2006-10-16
CN1454087A (zh) 2003-11-05
CA2395037C (en) 2008-09-02
US20030060481A1 (en) 2003-03-27
CA2395037A1 (en) 2001-06-21
JP2003530315A (ja) 2003-10-14
DE60029252T2 (de) 2007-07-05
MXPA02005727A (es) 2003-10-14
WO2001043745A1 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
MY133667A (en) Quinazoline ditosylate salt compounds
DE69941586D1 (de) Verwendung von Uridin in Kombination mit Cholin zur Behandlung von Gedächtnisstörungen
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
MY140679A (en) Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
DE69838338D1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
DK0882021T3 (da) Nye phenanthridiner
DE3579891D1 (de) N-((4,6-dimethoxypyrimidin-2-yl)aminocarbonyl)-3-trifluoromethylpyridin-2-sulfonamide oder salze davon, diese enthaltendes herbizides mittel und verfahren zur herstellung dieser verbindung.
WO2003026478A3 (en) System and method for diagnosing and/or reducing tinnitus
MX9700886A (es) Nuevas oxazolidinonas sustituidas.
BR0111898A (pt) Métodos de tratamento de doenças de proliferação celular, e de um distúrbio associado com a atividade de cinesina ksp, método de inibição da cinesina ksp, composto, método de triagem de moduladores da cinesina kps, e, método de triagem de compostos que se ligam à cinesina ksp
CU23126A3 (es) Inhibicion de kinasa raf usando ureas heterociclicas sustituidas
DE68919436D1 (de) Stabilisierter, aus Fäden bestehender Vliesstoff.
DE60100625D1 (de) Verwndung von verbindungen mit 5-ht1a aktivität zur behandlung von krankheiten der äusseren retina
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
DE69718347D1 (de) VERWENDUNG EINER ZUSAMMENSETZUNG AUS H+, K+ -ATPase-INHIBITOREN UND GLUCOCORTIKOIDEN ZUR BEHANDLUNG VON NASENPOLYPEN
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
ATE390130T1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
UY26426A1 (es) Nuevos compuestos
DE3688844D1 (de) Synergistische, herbizide kombinationen und verfahren zur anwendung.
ATE332137T1 (de) Anwendung von scopolaminsalzen
DE59208144D1 (de) Stämme des pilzes trichoderma, daraus hergestelltes fungizid, sowie verfahren zu dessen anwendung
DE60020833D1 (de) Melatonin zur behandlung von paralysen ausgelöst durch hirnschlag
ATE397923T1 (de) Verwendung von antimuscarinischen arzneimitteln
DE69926996D1 (de) Verwendung von riluzol zur behandlung der retinalischemie
DK1121108T3 (da) Ny terapeutisk anvendelse af forbindelser med beta-3-agonistaktivitet

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: DE MORAES MELLO, EUGENIO, LUIZ, CEP-05502-060 SAO

Inventor name: GONCALVES MASSANT, CHRISTINA, R. BERTIOGA, CHACARA

Inventor name: KASTROPIL BENASSI, SIMONE, SAO PAULO, SP, BR

8364 No opposition during term of opposition